Explore all of ul.com

Health Canada has issued Notice to interested parties — Non-prescription availability of low-dose codeine products for public consultation.

This notice specifies that all products containing codeine should be sold by prescription only. This notice seeks comments on the potential risks, benefits, and impacts of changes to the regulations to the Controlled Drugs and Substances Act regarding all products containing codeine.

Codeine is an opioid drug that is used to treat mild to moderate pain and cough.

Source

Share

Subscribe to Newsletter

The CRS monthly Newsletter focuses on the latest initiatives, insights and information for manufacturers and retailers across industries.